Biliary tree malignancies: The University of Minnesota experience

Journal of Surgical Oncology

Volumn 65, Issue 4, 1997, Pages 298-305

  Lee, Chung K ^a   Barrios, Bennet R ^a   Bjarnason, Haraldur ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Biliary tract neoplasms; Brachytherapy; Iridium radioisotopes; Radiotherapy

Indexed keywords

BILIARY TRACT CANCER; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER SURVIVAL; PRIORITY JOURNAL; REVIEW; TREATMENT PLANNING;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; BILE DUCT NEOPLASMS; BILE DUCTS, EXTRAHEPATIC; BRACHYTHERAPY; CATHETERIZATION; COMBINED MODALITY THERAPY; DRAINAGE; FEMALE; HUMANS; IRIDIUM RADIOISOTOPES; MALE; MIDDLE AGED; RADIOTHERAPY DOSAGE; SURVIVAL ANALYSIS;

EID: 0030871248     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9098(199708)65:4<298::AID-JSO12>3.0.CO;2-Z     Document Type: Review

References (27)

1. Parker SL, Tong T, Bolden S, Wingo PA: Cancer statistics, 1996 [see comments, 3-4] CA Cancer J Clin 1996;46:5-27.
2. Keller JW, Peacock JL, Smith JL: Cancer of the major digestive glands: pancreas, liver, bile ducts, gallbladder. In Rubin P, McDonald S. Qazi R (eds): "Clinical Oncology," 7th ed. Philadelphia: W.B. Saunders, 1993, p 607-610.
3. Vauthey JN, Blumgart LH: Recent advances in the management of cholangiocarcinomas [Review]. Semin Liver Dis 1994;14:109-114.
4. Parkin DM, Ohshima H, Srivatanakul P, Vatanasapt V: Cholangiocarcinoma: Epidemiology, mechanisms of carcinogenesis and prevention [Review]. Cancer Epidemiol Biomarkers Prev 1993;2: 537-544.
5. Minsky BD, Kemeny N, Armstrong JG,et al.: Extrahepatic biliary system cancer: An update of a combined modality approach. Am J Clin Oncol 1991;14:433-437.
6. Klatskin G: Adenocarcinoma of the hepatic duct at its bifurcation within the porta hepatis. Am J Med 1965;38:241-256.
7. Kopelson G, Galdabini J, Warshaw AL, Gunderson LL: Patterns of failure after curative surgery for extra-hepatic biliary tract carcinoma: Implications for adjuvant therapy. Int J Radiat Oncol Biol Phys 1981;7:413-417.
8. Stain SC, Baer HU, Dennison AR, Blumgart LH: Current management of hilar cholangiocarcinoma [Review]. Surg Gynecol Obstet 1992; 175:579-588.
9. Curley SA, Levin B, Rich TA: Liver and bile ducts. In Abeloff MD, Armitage JO, Lichter AS, et al. (eds): "Clinical Oncology." New York: Churchill Livingstone, 1995, p 1305-1372.
10. Beahrs OH, Henson DE, Hutter RV, et al.: "American Joint Committee on Cancer Manual for Staging of Cancer," 4th ed. Philadelphia: Lippincott, 1992.
11. Kamada T, Saitou H, Takamura A, et al.: The role of radiotherapy in the management of extrahepatic bile duct cancer: an analysis of 145 consecutive patients treated with intraluminal and/or external beam radiotherapy. Int J Radiat Oncol Biol Phys 1996; 34:767-774.
12. Tompkins RK, Thomas D, Wile A, Longmire WP Jr: Prognostic factors in bile duct carcinoma: Analysis of 96 cases. Ann Surg 1981;194:447-457.
13. Gunderson LL, Willet CG: Pancreas and hepatobiliary tract. In Perez CA, Brady LW (eds): "Principles and Practice of Radiation Oncology," 2nd ed. Philadelphia: Lippincott, 1992, p 985-999.
14. Lotze MT, Flickinger JC, Carr BI: Hepatobiliary neoplasms. In DeVita VT, Hellman S, Rosenberg SA (eds): "Cancer: Principles and Practices of Oncology," 4th ed. Philadelphia: Lippincott, 1993, p 883-914.
15. Gunderson LL, Martin JK, Kvols LK, et al.: Intraoperative and external beam irradiation + 5-FU for locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys 1987;13:319-329.
16. Rich TA, Evans DB, Curley A, Ajan JA: Adjuvant radiotherapy and chemotherapy for biliary and pancreatic cancer. Ann Oncol 1994;5 (Suppl 3):575-580.
17. Hayes JK Jr, Sapozink MD, Miller FJ: Definitive radiation therapy in bile duct carcinoma. Int J Radial Oncol Biol Phys 1988;15: 735-744.
18. Mahe M, Romestaing P, Talon B, et al.: Radiation therapy in extrahepatic bile duct carcinoma. Radiother Oncol 1991;21:121-127.
19. Gonzalez Gonzalez D, Gerard JP, Maners AW, et al.: Results of radiation therapy in carcinoma of the proximal bile duct (Klatskin tumor). Semin Liver Dis 1990;10:131-141.
20. Wolkov HB, Graves GM, Won M, et al.: Intraoperative radiation therapy of extrahepatic biliary carcinoma: a report of RTOG-8506. Am J Clin Oncol 1992;15:323-327.
21. Johnson DW, Safai C, Goffinet DR: Malignant obstructive jaundice: treatment with external beam and intracavitary radiotherapy. Int J Radial Oncol BiolPhys 1985;11:411-416.
22. Fields JN, Emami B: Carcinoma of the extrahepatic biliary system - results of primary and adjuvant radiotherapy. Int J Radial Oncol Biol Phys 1987;13:331-338.
23. Pilepich MV: Radiation for carcinoma of the extrahepatic bile duct and radiotherapy in carcinoma of the gallbladder. In Wanebo HJ (ed): "Hepatic and Biliary Cancer." New York: Marcel Dekker, 1987, p 417-427, 447-452.
24. Alden ME, Mohiuddin M: The impact of radiation dose in combined external beam and intraluminal IR-192 brachytherapy for bile duct cancer. Int J Radiat Oncol Biol Phys 1994;28:945-951.
25. Buskirk SJ, Gunderson LL, Schild SE, et al.: Analysis of failure after curative irradiation of extrahepatic bile duct carcinoma. Ann Surg 1992;215:125-131.
26. Stevens KR: The liver and biliary system. In Cox JD (ed): "Moss Radiation Oncology: Rationale, Technique, Results." 7th ed. St. Louis: Mosby, 1994, p 452-461.
27. Mogavero GT, Jones B, Cameron JL, Coleman J: Gastric and duodenal obstruction in patients with cholangiocarcinoma in the porta hepatis: Increased prevalence after radiation therapy. Am J Roentgenol 1992;159:1001-1003.